Table 1.
Baseline characteristics of the study population in AKI and stable CKD groups median (IQR 25–75%).
| AKI | Stable CKD | P values | |
|---|---|---|---|
| Gender M/F | 14/11 | 11/11 | 0.89 |
| Age-years | 68 (57–76) | 68 (56–76) | 0.97 |
| GFR, ml/min/1.73 m2 | 38 (23–56) | 42 (32–57) | 0.1 |
| Creatinine, mg/dl | 2.15 (1.80–2.98) | 2.07 (1.64–2.33) | 0.08 |
| BUN mg/dl | 50 (40–71) | 39 (31–48) | 0.01 |
| Hemoglobin, g/dl | 11.5 (10.5–12.8) | 11.2 (10.4–12.1) | 0.4 |
| White blood cell (103/mm3) | 12.7 (10.5–15.8) | 10 (8–11) | <0.001 |
| pH | 7.38 (7.30–7.40) | 7.38 (7.34–7.40) | 0.8 |
| HCO3, mEq/L | 24 (21–27) | 24 (21–26) | 0.8 |
| PCO2 mmHg | 42 (39–44) | 40 (38–44) | 0.4 |
| Sodium, mmol/L | 137 (133–140) | 140 (135–141) | 0.1 |
| Potassium, mmol/L | 4.6 (4.1–5.0) | 4.5 (4.0–5.1) | 0.8 |
| Plasma NGAL, ng/ml | 794 (317–1300) | 390 (219–664) | 0.02 |
AKI: Acute kidney injury, CKD: Chronic kidney disease, GFR: Glomerular filtration rate.